[Skip to content](#main) 

Take a question to your next care conversation.

[Kansas Peptide Therapy](/) 

Kansas therapy regulations in checklist form, with friendly notes. Dispenses no drugs.

[Who is allowed to treat?](/rules-desk) [How would a remote visit work?](/telehealth-desk) [Which charges are included?](/money-desk) [What needs prompt attention?](/safety-desk) 

[Home](/) /Pharmacy checks

# Check the pharmacy behind the prescription

Ask who will fill the prescription and, if it is compounded, who will make it. Keep the full pharmacy name, the record supplied by the service and the proposed product together. A website name can stay the same while the pharmacy details need a separate explanation.

When a compounded drug is obtained online, [the person receiving it may not be told who made it](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) , notes FDA, the federal drug agency.

☐ 

## Look up the actual pharmacy

The [Kansas Board of Pharmacy portal](https://ksbop.elicensesoftware.com/portal.aspx)  provides public pharmacy and pharmacist verification.

Use the name the dispensing service gives you, rather than just the name in an advertisement. If a record is hard to find, ask for the name as registered and the registration number. Compare the answer with the board record. Keep a note of the date you checked and what still needs an answer.

Pharmacy details have been falsified on labels for compounded weight drugs, FDA reports: [some semaglutide and tirzepatide labels name nonexistent pharmacies](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) . This information was checked November 3, 2026.

☐ 

## Ask about delivery into Kansas

Kansas law, reviewed November 3, 2026, says [a pharmacy in another state needs Kansas registration to send prescriptions here](https://www.kslegislature.gov/b2025_26/laws/065_000_0000_chapter/065_016_0000_article/065_016_0057_section/065_016_0057_k/) . The board may make exceptions for lawful refills first filled in the pharmacy’s own state and for isolated transactions.

That Kansas registration is called “nonresident” registration because the pharmacy is outside the state. Ask where it can be checked. If an exception is claimed, ask for the specific basis and raise an unclear answer with the pharmacy board. Avoid assuming that a registration in its home state settles the Kansas question.

Keep the delivery name with the proposed prescription. This helps when asking whether the same pharmacy will handle later fills or whether the service may change the arrangement.

☐ 

## Get a route to the pharmacist

As of November 3, 2026, Kansas law requires a nonresident pharmacy to offer [toll-free access to a pharmacist who can see the patient’s records](https://www.kslegislature.gov/b2025_26/laws/065_000_0000_chapter/065_016_0000_article/065_016_0057_section/065_016_0057_k/) , with the number on the prescription container’s label.

The law also requires written procedures for delivery delays and unavailable medicine.

Ask how a delivery question reaches the pharmacy and how a medicine question reaches a pharmacist. Find out what happens if the expected delivery does not arrive. Keep those answers where you can find them later. A general customer-service reply may leave a pharmacy question unanswered, so ask which route applies.

☐ 

## Separate registration from product approval

A facility’s [FDA registration is not FDA approval](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-207/subpart-F/section-207.77)  of that facility or its products, under the position recorded on November 3, 2026.

Ask what each badge or phrase on an offer is meant to establish. The pharmacy’s record, the product’s status and the prescriber’s reason for choosing it are distinct topics. Put each answer on its own line so a broad claim does not stand in for all of them.

For a compounded prescription, take the next question to the compounding desk: what need would this preparation meet? Which ingredient and form are proposed? If a label or record does not match the answer, keep it and ask the pharmacy to reconcile the details before treating the matter as settled.

Ask whether the pharmacy can provide a written summary of these details. Keep it with the care notes, rather than in a separate message that will be hard to find. Bring an unanswered supply question into the next conversation with the prescriber.

## Source notes

[FDA compounding questions](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) 

[Kansas pharmacy verification](https://ksbop.elicensesoftware.com/portal.aspx) 

[FDA weight-drug concerns](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) 

[Kansas nonresident pharmacy law](https://www.kslegislature.gov/b2025_26/laws/065_000_0000_chapter/065_016_0000_article/065_016_0057_section/065_016_0057_k/) 

[Federal registration rule](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-207/subpart-F/section-207.77) 

[Continue to compounding](/compounding-desk) 

## First questions

[Peptide basics](/welcome-desk) [Kansas rules](/rules-desk) 

## Who handles care

[License checks](/license-desk) [Online visits](/telehealth-desk) [Pharmacy checks](/pharmacy-desk) 

## The medicine

[Compounding](/compounding-desk) [Weight medicines](/weight-care-desk) [Medicine problems](/safety-desk) 

## The bill

[Costs](/money-desk) [Insurance](/coverage-desk) 

## For a conversation

[Visit checklist](/help-desk) [Sources and concerns](/source-desk) 

These Kansas checklists are a guide to asking about care, not a clinic or a place that supplies medicine.

© Kansas Peptide Therapy